These press releases are intended for business journalists and analysts/investors
GSK invests in Victorian manufacturing with Monash and the Victorian Government as founding partner of the Medicines Manufacturing Innovation Centre.
Read more - GSK founding partner for Victorian Medicines Manufacturing Innovation Centre Read more
GSK prioritises whooping cough vaccine availability for those most at risk of the disease and confirms uninterrupted supply of Boostrix® and Boostrix® IPV to all Australian State, Territory and Federal Government vaccination programs where Boostrix/Boostrix-IPV is the vaccine of choice.
Read more - Whooping cough vaccines availability update Read more
Read more - Anne Belcher to succeed Geoff McDonald as GSK Australia general manager Read more
GSK publishes Medicines Australia transfer of value report
Read more - GSK publishes transfer of value report Read more
• Leading lifestyle commentator Shelly Horton reveals hay fever struggle
• Over 3 million Australians could be affected by hay fever season
• Up to 8 in 10 people with asthma also affected by hay fever
Read more - Experts urge hay fever sufferers to get symptoms under control Read more
Read more - New VentureWise program on COPD and asthma Read more
- GSK Australia supplies travel vaccines for Olympic Team
Read more - Bactroban (mupirocin) 2% Ointment supply Read more
- Changes trigger better access to the treatment of enlarged prostate
- GPs set to play a more prominent role in managing moderate to severe BPH.
